维普中文期刊产品整合服务
133篇 您的检索式:作者名="Slichter"
    题名 作者 年代 出处 被引量
1血小板输血治疗的新观点显示文摘预防性血小板输血的阈值水平 当前血小板输血前检查,预防性血小板输血的阈值分别为20,000与10,000血小板/μL,这两种情况的失血没有不同,但采用低阈值输注血小板将减少22%-33%血小板的使用。血小板剂量对血小板输血频度的影响 血小板计数≤70000血小板/μL时,血小板计数与血小板存活率有直接关系。从而患者的血小板输血后血小板计数较高、两次输血间隔时间延长。计算机模型表明较低的血小板剂量(3对6单位血小板混合)将减少血小板总的需求量。Slichter SJ 王军 2002国外医学(输血及血液学分册)2002,25,1:4
2Evidence-based platelet transfusion guidelines显示文摘Slichter SJ 2007Hematology Am Soc Hematol Educ Program2007,,:1
3Dysbaric osteonecrosis:a consequence of intravascular bubble formation,endothelial damage,and platelet thrombosis显示文摘Slichter SJ Stegall P Smith K 1981J Lab Clin Med1981,98,4:1
4Evaluation of different methods of leukoreduction of donor paltelets to prevent alloimmune platelet refractoriness and induce tolerance in a canine transfusion model显示文摘Slichter SJ Fish D Abrams VK 2005Blood2005,105,2:1
5New strategies for the optimal use of platelet transfusions显示文摘Blajchman MA Slichter SJ Heddle NM 2008Hematology Am Soc Hematol Educ Program2008,2008,1:1
6Corrected count increment and percent platelet recovery as measures of poettransfusion platelet response: problems and a solution显示文摘Davis KB Slichter SJ Corash L 1999Transfusion1999,39,6:1
7Use of leukocytedepleted platelets and cytomegalovirus-seronegative red blood cells for prevention of primary cytomegalovirus infection after marrow transplant显示文摘Bowden RA Slichter SJ Sayers MH 0,,01:1
8Observa- tion of the Free Oscillation of the Earth显示文摘Ness N R Harrison C T Slichter L B 1961J Geo- phys Res1961,66,2:1
9A comparison of filtered leukocyte-reduced and cytomegalovirus (CMV)seronegative blood products for the prevention of transfusionassociated CMV infection after marrow transplant显示文摘Bowden RA Slichter SJ Sayers M 0,,09:1
10Factors affecting posttransfusion platelet increments, platelet refractoriness, and platelet transfu- sion intervals in thrombocytopenic patients显示文摘Slichter SJ Davis K Enright H 2005Blood2005,,10:1
11Persistence of lym- phocytotoxic antibodies in patients in the trial to reduce alloimmunization to platelets : implications for using modi- fied blood products显示文摘Slichter SJ Bolgiano D Kao KJ 2011Transfus Med Rev2011,25,2:1
12Relationship between platelet count and bleeding risk in thrombocytopenic patients显示文摘Slichter SJ 2004Trans Med Rev2004,18,3:1
13Controversies in patelet transfusion therapy显示文摘Slichter S J 1980Annual Rev Med1980,31,:1
14Notes on the Structure of Wages 显示文摘Slichter Sumner 1950Review of Economics and Statistics1950,32,:1
15Platelet transfusion therapy 显示文摘Slichter SJ 2007Hematol Oncol Clin North Am2007,21,4:1
16Homocysteine levels in patients with ischemid cerebral 显示文摘Harker LA Slichter SJ Scott CR 1998Med Clin ( Barc)1998,291,3:1
17Evidence-based platelet transfusion guidelines 显示文摘Slichter SJ 2007Hematology Am Soc Hematol Educ Program2007,2007,1:1
18Transient increase in circulating donor leukocytes after allogeneic transfusions in immunocompetent recipients compatible with donor cell proliferation 显示文摘Lee TH Donegan E Slichter S 1995Blood1995,85,5:1
19Evaluation of different methods of leukoreduction of donor platelets to prevent alloimmune platelet refractoriness and in- duce tolerance in a canine transfusion model 显示文摘Slichter S J Fish D Abrams VK 2005Blood2005,105,2:1
20Platelet kinetics in patients with bone marrow hypoplasia:evidence for a fixed platelet requirrement 显示文摘Hanson S R Slichter S I 1985Blood1985,66,:1
返回顶部 每页显示:
共7页 首页 上一页 第1页 下一页 末页 /7 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费